Peanut allergy patch offers hope for kids
NCT ID NCT05424731
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This program provides continued access to the Viaskin Peanut skin patch for children aged 2 and older with peanut allergy who previously completed a DBV712 study. The patch delivers a small amount of peanut protein through the skin each day to help desensitize the immune system. The goal is to reduce the risk of severe allergic reactions from accidental peanut exposure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Viaskin Peanut (DBV712) skin patch
What this could lead to
If successful, this program could help children with peanut allergy tolerate small amounts of peanut, reducing the risk of severe reactions from accidental exposure.
What could go wrong
This is an expanded access program, not a formal trial, so results are limited. The patch may cause skin irritation, and it does not cure the allergy—ongoing use is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Xolair for Peanut Allergy Study (NCT00382148)
- Biologics for Multi-Food Allergy OIT (NCT03679676)
- MOON101 Peanut Allergy Safety Trial (NCT07580898)
- NATASHA Study: Using everyday foods for allergy NCT05503446
- ENP-501 Peanut Allergy Trial Phase 1/2 (NCT07117669)
- FMT for Peanut Allergy Trial (NCT02960074)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Early Access Care, LLC
AVAILABLEMadison, Connecticut, 06443, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••